Ketamine Hydrochloride Injection, Solution, Concentrate
Product Images NDC 0409-0040
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ketamine Hydrochloride (NDC 0409-0040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Ketamine Hydrochloride 02)
Principal Display Panel (5 mL Vial Label)
This is a description of a medication called Ketamine HCI. It is a concentrate injection used for slow intravenous or intramuscular use, and must be diluted prior to intravenous use. The medication comes in a multiple-dose vial with each mL containing 115.3 mq Ketamine Hydrochloride equivalent to 100 mg of Ketamine base and 0.1 mg of benzethonium chloride added as preservative. The dosage information is available in the full prescribing information. The medication should be stored in a controlled room environment and protected from light. This medication is distributed by a company called Hospira, Inc.*
Principal Display Panel (5 mL Vial Box)
This is a product description for 5mL multiple-dose vials of Ketamine Hydrochloride Injection, USP with a concentration of 500mg/5mL (100mg/mL). The vials are for slow intravenous or intramuscular use and must be diluted before intravenous use. The brand name is novaplus. The vials come in a box containing 10. The text provides information on dosage, storage temperature (20° to 25°C), and the chemical composition of the solution.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.